Metting P J, Kostrzewski K A, Stein P M, Stoos B A, Britton S L
Department of Physiology and Biophysics, Medical College of Ohio, Toledo, 43699-0008.
J Clin Invest. 1989 Dec;84(6):1900-5. doi: 10.1172/JCI114377.
Experiments were performed in nine conscious dogs to quantitate the contribution of systemic vascular autoregulation to the increases in total peripheral resistance (TPR) and mean arterial pressure (MAP) produced by angiotensin II (ANG II), arginine vasopressin (AVP), and norepinephrine (NE). We hypothesized that if autoregulatory vasoconstriction is significant, then the increase in TPR produced by vasoconstrictor infusion will be greater when MAP is controlled at hypertensive values than when the increase in pressure is prevented by controlling MAP at the animal's normotensive value. Each drug was infused at a dose sufficient to increase MAP by 50%. Then, a constant rate of vasoconstrictor infusion was maintained while MAP was controlled at hypertensive or normotensive levels for 15-min periods using a gravity reservoir connected to the left common carotid artery. During AVP infusion, TPR was significantly greater when MAP was controlled at hypertensive than at normotensive values. This autoregulatory-mediated vasoconstriction accounted for approximately three-fourths of the increase in MAP produced by AVP. No significant autoregulatory component was identified for the increases in TPR and MAP produced by ANG II or NE. We conclude that systemic vascular autoregulation is a powerful physiological property that contributes to the hemodynamic response to pressor doses of AVP.
在9只清醒犬身上进行了实验,以定量评估全身血管自动调节对血管紧张素II(ANG II)、精氨酸加压素(AVP)和去甲肾上腺素(NE)所引起的总外周阻力(TPR)增加和平均动脉压(MAP)升高的作用。我们假设,如果自动调节性血管收缩作用显著,那么当将MAP控制在高血压值时,与通过将MAP控制在动物的正常血压值来防止血压升高相比,血管收缩剂输注所引起的TPR增加会更大。每种药物均以足以使MAP升高50%的剂量进行输注。然后,在使用连接到左颈总动脉的重力储液器将MAP控制在高血压或正常血压水平15分钟的过程中,维持血管收缩剂的恒定输注速率。在输注AVP期间,当MAP控制在高血压值时,TPR显著高于控制在正常血压值时。这种自动调节介导的血管收缩约占AVP所引起的MAP升高的四分之三。对于ANG II或NE所引起的TPR和MAP升高,未发现显著的自动调节成分。我们得出结论,全身血管自动调节是一种强大的生理特性,它有助于对加压剂量的AVP产生血流动力学反应。